Molecular Mechanism of Enhanced Anticancer Effect of Nanoparticle Formulated LY2835219 via p16-CDK4/6-pRb Pathway in Colorectal Carcinoma Cell Line

Figure 3

Cell cycle arrest at G1 phase by LY2835219 and its nanoparticle formulations.

(a)

(b)